Načítá se...
Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins
Patients with immunodeficiencies or some types of autoimmune diseases rely on a safe therapy with intravenous immunoglobulins (IVIGs) manufactured from human plasma, the only available source for this therapeutic. Since plasma is predisposed to contamination by a variety of blood-borne pathogens, as...
Uloženo v:
| Vydáno v: | Biologicals |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The International Association for Biologicals. Published by Elsevier Ltd.
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7129354/ https://ncbi.nlm.nih.gov/pubmed/16581263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biologicals.2006.01.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|